sciencePeptideDosage

How to Reconstitute Peptides: Step-by-Step Mixing Guide with Bacteriostatic Water

Complete reconstitution guide for lyophilized peptides — bacteriostatic water selection, mixing math, step-by-step procedure, BPC-157 example and dilution table.

verifiedMedically reviewed byPeptideDosage Editorial Board
eventLast reviewed

Reconstitution is the process of dissolving a lyophilized (freeze-dried) peptide powder into a sterile aqueous diluent — usually bacteriostatic water for injection (BAC water) containing 0.9% benzyl alcohol — to produce an injectable solution at a known concentration. Done correctly, reconstitution preserves peptide potency, prevents microbial contamination, and lets you calculate dose volumes accurately. Done incorrectly, it foams the peptide, denatures sensitive sequences, or seeds bacterial growth that ruins the vial long before its 28-day window closes.

This guide is a procedural reference. It walks through the supplies you actually need, why BAC water is the correct diluent (rather than sterile saline or plain water for injection), the concentration math, the step-by-step injection technique, and the volume-to-unit conversions you will use every time you draw a dose. It includes a quick-reference table for common vial sizes — BPC-157, tirzepatide, semaglutide, retatrutide — and identifies the most common reconstitution mistakes. This procedure should only be performed on research peptides; it is not medical advice.

Supplies checklist: what you need before opening the vial

Reconstitution is a sterile procedure. Lay out every supply before you start so the vial sits open for as little time as possible.

  • Lyophilized peptide vial — stored refrigerated until ready to mix. Allow it to come to room temperature (about 15 minutes on the bench) before opening — condensation on cold glass can introduce water into the vial when you pop the cap.
  • Bacteriostatic water for injection (BAC water), USP-grade, 0.9% benzyl alcohol — 10 mL or 30 mL multi-dose vial. Not sterile water for injection and not 0.9% sodium chloride.
  • U-100 insulin syringes — 0.3 mL (30 unit) or 0.5 mL (50 unit) barrels, 29–31 G, 8 mm needle. One syringe per draw for measuring; one separate syringe per injection.
  • 3 mL or 5 mL transfer syringe with 21–23 G needle — optional but convenient for drawing BAC water in larger volumes from a stoppered vial.
  • 70% isopropyl alcohol swabs — at least 6–8 per session.
  • Clean flat work surface — wiped with isopropyl, well lit, away from drafts and dust.
  • FDA-approved sharps container for disposal.
  • Permanent marker and labels for marking the reconstitution date and concentration on the vial.
  • Powder-free gloves — optional but recommended.

Do not reuse needles between draws. Each pass through the rubber stopper coring's a microscopic fragment of stopper rubber into the vial and increases the chance of contamination [1][2].

Why bacteriostatic water and not sterile saline?

Three diluents are commonly considered for peptide reconstitution. Only one is appropriate for multi-dose use.

Bacteriostatic water for injection (BAC water) — correct

USP-grade BAC water is sterile water containing 0.9% benzyl alcohol as a bacteriostatic preservative. The benzyl alcohol inhibits the growth of common contaminants such as Staphylococcus epidermidis, Staphylococcus aureus, E. coli and Pseudomonas, allowing a multi-dose vial to be re-entered safely over a 28-day window after first puncture [3][4]. This is the standard solvent for any peptide vial that will be drawn from more than once. Confirm the label states 0.9% benzyl alcohol; lower-concentration or 'preservative-free' bacteriostatic water is not equivalent.

Sterile water for injection (SWFI) — wrong for multi-dose

Plain SWFI has no preservative. Once punctured, it cannot be safely re-entered after a few hours. It is acceptable only for single-use vials prepared and injected within minutes. For peptide research workflows where one 5 mg or 10 mg vial is drawn from over 4–6 weeks, SWFI is the wrong choice.

0.9% sodium chloride (normal saline) — wrong for most peptides

Saline is hypertonic relative to many peptide solutions, has no antimicrobial preservative in standard preparations, and can alter the pH and ionic environment of certain sequences. It is occasionally specified for single-use IV preparations under hospital pharmacy supervision but is not a general-purpose peptide diluent.

Acetic acid solutions — niche use only

A small number of peptides (a few hydrophobic GH-secretagogues, certain bioregulators) are difficult to dissolve in BAC water and are reconstituted in 0.6% acetic acid or 1% benzyl-alcohol-acidified water. Follow the supplier's COA — do not switch to acidified diluent unless explicitly required, because the lower pH will accelerate degradation of pH-sensitive peptides [5].

The reconstitution math: vial mg ÷ water mL = concentration

The concentration of the reconstituted solution is determined entirely by how much water you add to the vial. The formula is simple but worth committing to memory:

Concentration (mg/mL) = Peptide mass in vial (mg) ÷ Volume of BAC water added (mL)

Worked example — BPC-157

A common BPC-157 vial contains 5 mg. Reconstituting with 2 mL of BAC water gives:

5 mg ÷ 2 mL = 2.5 mg/mL

If a protocol calls for 250 mcg (0.25 mg) per dose, the volume to draw is 0.25 mg ÷ 2.5 mg/mL = 0.1 mL, which is 10 units on a U-100 insulin syringe.

Worked example — Tirzepatide

A 10 mg tirzepatide vial reconstituted with 2 mL of BAC water gives:

10 mg ÷ 2 mL = 5 mg/mL

A 2.5 mg titration dose is 2.5 mg ÷ 5 mg/mL = 0.5 mL = 50 units. A 5 mg dose is 1.0 mL = 100 units. A 10 mg vial at this concentration provides four 2.5 mg doses or two 5 mg doses.

Common dilution presets

Vial size (mg)BAC water (mL)Concentration (mg/mL)Typical use
21.02.0Small peptides, low-dose protocols
51.05.0BPC-157, TB-500 concentrated
52.02.5BPC-157, TB-500 standard
52.52.0BPC-157 dilute for split dosing
101.010.0Concentrated GLP-1 dosing
102.05.0Tirzepatide standard, BPC-157 high-dose
102.54.0Semaglutide titration
153.05.0Retatrutide standard
303.010.0Multi-week tirzepatide supply

Choose the dilution that puts your target dose between 10 and 50 units on a U-100 syringe. Doses smaller than 5 units are difficult to measure accurately; doses larger than 50 units waste solution and require multiple draws.

Step-by-step reconstitution procedure

Allow both the peptide vial and the BAC water vial to sit at room temperature for 10–15 minutes before starting. Wash your hands and put on gloves if using.

  1. Prepare the work surface. Wipe with 70% isopropyl. Lay out all supplies within arm's reach.
  2. Remove the plastic flip-tops from the peptide vial and the BAC water vial. This exposes the rubber stoppers. Do not remove the metal crimp underneath.
  3. Swab both stoppers with a fresh alcohol pad. Let dry for 5–10 seconds — wet alcohol can be drawn into the vial.
  4. Draw the bacteriostatic water. Using a U-100 insulin syringe (or a 3 mL syringe for larger volumes), pull back the plunger to your target water volume — pull a small amount of air first, inject it into the BAC water vial to equalize pressure, then withdraw the correct volume. Tap the syringe to release bubbles, then push them back into the vial and re-draw.
  5. Inject the water into the peptide vial. Insert the needle into the peptide vial at an angle so the tip points to the inside wall of the glass. Release the BAC water slowly down the wall — do not spray it directly onto the powder. Direct impact can foam the peptide, denaturing sensitive sequences and trapping micro-bubbles that interfere with later draws.
  6. Equalize pressure. Before withdrawing the empty syringe, pull back the plunger slightly to draw any vacuum out of the vial. This prevents the rubber stopper from popping back at you.
  7. Allow the peptide to dissolve. Set the vial upright. The lyophilized cake will dissolve over 30–90 seconds — sometimes faster. Do not shake. If small visible particles remain after 1–2 minutes, swirl gently in a horizontal circle, or rotate the vial slowly between your palms. The fully reconstituted solution should be clear and colorless.
  8. Label the vial. Write the reconstitution date, concentration in mg/mL, and a 28-day expiry on the side of the vial with permanent marker. Some users add a small adhesive label rather than writing on the glass directly.
  9. Refrigerate immediately at 2–8 °C. Do not freeze reconstituted solution. See our peptide storage guide for compound-specific shelf-life details.

Reconstitution should take under five minutes once the supplies are laid out. Practice the sequence with a sterile water vial before opening an expensive peptide.

Volume to units: converting mg, mcg and mL for U-100 syringes

Every dose is calculated in three steps: convert dose mass to mL using the concentration, then convert mL to insulin units. The standard conversion factor is:

1 mL on a U-100 syringe = 100 units, so 0.01 mL = 1 unit.

The unified formula:

Units = (Dose in mg ÷ Concentration in mg/mL) × 100

Or equivalently, if your dose is in micrograms:

Units = (Dose in mcg ÷ Concentration in mcg/mL) × 100

Worked example — 500 mcg BPC-157 from a 5 mg/mL vial

Dose = 500 mcg = 0.5 mg. Concentration = 5 mg/mL. Volume = 0.5 ÷ 5 = 0.1 mL = 10 units on a U-100 syringe.

Worked example — 2.5 mg tirzepatide from a 5 mg/mL vial

Dose = 2.5 mg. Concentration = 5 mg/mL. Volume = 2.5 ÷ 5 = 0.5 mL = 50 units.

Worked example — 250 mcg ipamorelin from a 2 mg/mL vial

Dose = 250 mcg = 0.25 mg. Concentration = 2 mg/mL. Volume = 0.25 ÷ 2 = 0.125 mL = 12.5 units. On a half-unit syringe this is read as the half-mark above the 12. On a whole-unit syringe, round to 12 or 13 units depending on protocol tolerance.

Our dedicated syringe measurement guide goes deeper on reading the barrel correctly, choosing the right syringe size, and avoiding the common error of reading from the wrong end of the plunger.

Pitfalls and mistakes to avoid

These are the issues that most often degrade peptide integrity or waste a vial.

Foaming and aggressive mixing

Peptides are surfactants — they accumulate at the air-water interface and can denature when a foam forms. Always inject BAC water down the wall of the vial. Never shake. Never sonicate. If the vial foams, set it aside for 10 minutes to let the foam collapse before drawing the first dose. Aggregation produced during foaming is partly irreversible and can reduce potency [5][6].

Freeze-thaw cycles

Reconstituted peptide solution should never be frozen. Ice formation concentrates the peptide into the unfrozen liquid pockets at high local concentration and physically disrupts the hydration shell, producing aggregation on thaw. Even a single freeze-thaw can reduce activity of sensitive peptides by 20% or more [6][7]. Refrigerate at 2–8 °C; if you need long-term storage, keep the lyophilized vial frozen and reconstitute only what will be used in 28 days.

Stopper coring and re-entry contamination

Each pass through a rubber stopper has a small probability of coring rubber fragments into the solution. Repeated entries also create micro-channels that can admit bacteria. Limit punctures to the minimum required, always use a fresh needle, and always swab the stopper before each entry [1][2].

Wrong needle sequence

Some users withdraw water with a thick 21 G needle, then swap to a 29–31 G insulin needle for the injection itself. This is fine, but only if you do it carefully — every needle change is another stopper puncture. The cleanest workflow uses the same insulin syringe to draw both BAC water and peptide solution.

Reconstituting at the wrong concentration

If your protocol calls for 0.5 mL doses but you reconstituted at high concentration so each dose is 0.05 mL, you'll struggle to measure accurately. Choose the dilution that puts your typical dose between 10 and 50 units on a U-100 syringe.

Skipping the date label

The 28-day reconstituted shelf-life starts at the moment water enters the vial. Without a label, you will lose track. Make labeling mandatory.

Compound-specific notes

BPC-157

Robust pentadecapeptide originally isolated from gastric juice. Stable across pH 2–10 and resistant to gastric enzymes. Reconstitutes readily in BAC water at concentrations up to 10 mg/mL with no detectable aggregation in animal-formulation studies [8][9]. Typical reconstitution: 5 mg vial in 2 mL BAC water → 2.5 mg/mL.

Tirzepatide and semaglutide

Long fatty-acid-acylated incretins. Reconstitute readily in BAC water; concentrated solutions (>10 mg/mL) may show slight cloudiness due to the acyl tail's affinity for itself — gently swirl and warm to room temperature to clarify. Typical reconstitution: 10 mg in 2 mL BAC water → 5 mg/mL.

Retatrutide

Triple agonist with a C20 fatty-acid chain similar to tirzepatide. Same handling principles apply. Typical reconstitution: 15 mg in 3 mL BAC water → 5 mg/mL, supporting weekly 2 mg–12 mg dosing across the full titration range.

Ipamorelin, CJC-1295 (no DAC)

Small synthetic peptides that dissolve quickly. Often blended in a single vial. Typical reconstitution: 5 mg of each combined in 2 mL BAC water → 2.5 mg/mL of each peptide for a standard 200 mcg + 200 mcg pre-bed dose at 8 units.

TB-500 (thymosin beta-4 fragment)

17-amino-acid peptide; reconstitutes cleanly in BAC water. Sensitive to repeated freeze-thaw — refrigerate the reconstituted vial and use within 28 days.

MOTS-c

16-amino-acid mitochondrially-encoded peptide. Reconstitutes well in BAC water but is unusually sensitive to repeated freeze-thaw of the lyophilized stock; ship and store cold-chain and minimize temperature cycling [10]. Typical reconstitution: 10 mg in 2 mL BAC water → 5 mg/mL.

Disposal and post-use handling

After every injection, recap the needle (if using a syringe with a safety sheath) or place the uncapped syringe directly into an FDA-approved sharps container. Do not recap freehand — it is the most common cause of accidental needle-sticks. Sharps containers should never be filled past two-thirds capacity and should be disposed of through a licensed medical-waste service or your local pharmacy's sharps drop-off program.

An expired vial — past the 28-day reconstituted window, or showing any cloudiness, color change, particulate matter, or separation — should be discarded. Do not 'top up' an expired vial with additional BAC water; the benzyl alcohol concentration is fixed at the original dilution, and adding more water dilutes it below the bacteriostatic threshold.

If you observe any of the following at any point, discard the vial: visible particulate matter floating in solution, persistent cloudiness after warming to room temperature and gentle swirling, yellow or brown discoloration, separation into oil-and-water-like layers, or stopper damage. These are signs of either microbial contamination or peptide aggregation, neither of which can be reversed [5][7].

Sterility expectations and the 28-day window

The 28-day post-reconstitution shelf life of a BAC-water vial is not a manufacturer's stability claim about the peptide itself — it is the duration over which 0.9% benzyl alcohol has been shown to inhibit microbial growth in repeated-puncture multi-dose vials [3][4]. Many peptides remain chemically potent considerably longer than 28 days in solution, but the bacteriostatic preservative is the limiting factor for safe injection. Some research workflows split the lyophilized vial in half before reconstitution and store one half frozen, then reconstitute the second half later — this preserves potency without violating the bacteriostatic window.

Quality checks before each draw

Every time you re-enter a vial, run a quick three-step check. First, inspect the solution against a dark background — it should be transparent and colorless with no visible particulates or fibers. Second, check the stopper seal and label — the date should still be within the 28-day window, the stopper intact, and the labeled concentration legible. Third, draw a small test volume to confirm the solution flows freely without unusual resistance or visible micro-bubbles streaming from the needle bevel. These three checks take under ten seconds and catch the most common quality issues before they reach the injection site.

Frequently Asked Questions

How much bacteriostatic water should I add to a 5 mg BPC-157 vial?expand_more

Most protocols use 2 mL of BAC water, producing a 2.5 mg/mL concentration. A 250 mcg dose then equals 0.1 mL or 10 units on a U-100 insulin syringe. If you prefer larger volumes (easier to measure on small syringes), use 2.5 mL of water for a 2.0 mg/mL concentration, where 250 mcg = 12.5 units.

Can I use distilled water or tap water to reconstitute peptides?expand_more

No. Distilled water and tap water are not sterile, are not pH-buffered, and contain mineral ions that can cause aggregation. Only USP-grade sterile bacteriostatic water for injection (0.9% benzyl alcohol) is appropriate for multi-dose peptide reconstitution. Single-use clinical reconstitution may use sterile water for injection [3][4].

Why shouldn't I shake a peptide vial?expand_more

Shaking creates foam at the air-water interface where peptides denature and aggregate. The same mechanical stress also breaks weak intramolecular hydrogen bonds, accelerating loss of biological activity. Always swirl gently or rotate the vial between your palms — never shake [5][6].

How long is a reconstituted peptide good for?expand_more

Most reconstituted peptides stored at 2–8 °C in bacteriostatic water remain potent for about 28 days, matching the BAC water antimicrobial window. Some peptides like MOTS-c degrade faster (14–21 days). Sensitive sequences should be split into smaller vials if you cannot use the volume within the window.

Should I shake or swirl after reconstitution?expand_more

Swirl gently in a horizontal circle, or rotate the vial slowly between your palms. The lyophilized cake usually dissolves within 30–90 seconds at room temperature without any agitation. If small particles remain, give it another 2–3 minutes before swirling. Shaking is never appropriate.

Can I mix two peptides in the same vial?expand_more

Yes, if they are pharmacologically compatible — common stacks include CJC-1295 + ipamorelin and BPC-157 + TB-500. Combine the lyophilized powders before adding BAC water, or add both into a single empty sterile vial. Confirm both are stable at the same pH and that the combined concentration is within solubility limits.

What happens if reconstituted peptide is accidentally frozen?expand_more

Discard it. Ice formation concentrates the peptide at the freezing front and disrupts the hydration shell, producing irreversible aggregation. Even a single freeze-thaw can reduce activity by 20% or more for sensitive peptides [6][7]. Always refrigerate; never freeze reconstituted solution.

Why do peptide vials sometimes appear empty?expand_more

Lyophilized peptide cakes are deceptively small — a 5 mg vial may look like a thin film stuck to the bottom or sides of the glass. This is normal. After adding BAC water, swirl gently; the visible cake dissolves into a fully transparent solution within 30–90 seconds.

References & Citations

  1. [1]

    USP General Chapter <797> Pharmaceutical Compounding — Sterile Preparations (2023 revision).View source →

  2. [2]

    ASHP Guidelines on Compounding Sterile Preparations (2014, Am J Health Syst Pharm).View source →

  3. [3]

    FDA — Bacteriostatic Water for Injection USP product labeling (Hospira/Pfizer).View source →

  4. [4]

    USP-NF Monograph: Bacteriostatic Water for Injection. United States Pharmacopeia.View source →

  5. [5]

    Manning MC, Chou DK, Murphy BM, et al. (2010) Pharm Res 27(4):544-575 — 'Stability of protein pharmaceuticals: an update.'View source →

  6. [6]

    Wang W (2000) Int J Pharm 203(1-2):1-60 — 'Lyophilization and development of solid protein pharmaceuticals.'View source →

  7. [7]

    Nugrahadi PP, Hinrichs WLJ, Frijlink HW, et al. (2023) Pharmaceutics 15(3):935 — 'Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review.'View source →

  8. [8]

    Sikiric P, Seiwerth S, Rucman R, et al. (2019) Inflammopharmacology 27:217-249 — 'BPC 157: Cytoprotection and Stress Coping.'View source →

  9. [9]

    Sikiric P, Drmic D, Sever M, et al. (2020) Curr Pharm Des 26(25):2901-2918 — 'Fistulas Healing: BPC 157 Pleiotropic Beneficial Effects.'View source →

  10. [10]

    Reynolds JC, Lai RW, Woodhead JST, et al. (2021) Nat Commun 12:470 — 'MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline.'View source →

  11. [11]

    Wang W (1999) Int J Pharm 185(2):129-188 — 'Instability, stabilization, and formulation of liquid protein pharmaceuticals.'View source →

  12. [12]

    Akers MJ (2002) J Pharm Sci 91(11):2283-2300 — 'Excipient-drug interactions in parenteral formulations.'View source →

  13. [13]

    Frokjaer S, Otzen DE (2005) Nat Rev Drug Discov 4(4):298-306 — 'Protein drug stability: a formulation challenge.'View source →

  14. [14]

    FDA Guidance for Industry — Sterile Drug Products Produced by Aseptic Processing.View source →

  15. [15]

    Bhatnagar BS, Bogner RH, Pikal MJ (2007) Pharm Dev Technol 12(5):505-523 — 'Protein stability during freezing.'View source →